Complementary and Alternative Medicine Therapies to Promote Healthy Moods

Pediatric Clinics of North America

Volumn 54, Issue 6, 2007, Pages 901-926

  Kemper, Kathi J ^a   Shannon, Scott ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Northern Colorado Center for Holistic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CALCIUM; CHROMIUM; CITALOPRAM; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FLUOXETINE; FOLIC ACID; HYPERICUM PERFORATUM EXTRACT; ICOSAPENTAENOIC ACID; INOSITOL; IRON; KIRA; LI 160 S; LINOLENIC ACID; MAGNESIUM; MINERAL; MULTIVITAMIN; PERIKA; PYRIDOXINE; REMOTIV; S ADENOSYLMETHIONINE; TRYPTOPHAN; UNCLASSIFIED DRUG; VITAMIN; VITAMIN D; WS 5570; WS 5572; ZE 117; ZINC;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANOREXIA; BEHAVIOR THERAPY; BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DIET SUPPLEMENTATION; DRUG MEGADOSE; ENVIRONMENT; EVIDENCE BASED MEDICINE; EXERCISE; GENETIC VARIABILITY; HEADACHE; HERB; HUMAN; HYPERICUM PERFORATUM; LANGUAGE; LIFESTYLE MODIFICATION; MAJOR DEPRESSION; MASSAGE; MEDITATION; MENTAL HEALTH; MOOD DISORDER; NATURAL SCIENCE; NAUSEA; NUTRITION; POLLUTION; RECOMMENDED DRUG DOSE; RELIGION; REST; REVIEW; SENSORY NEUROPATHY; SIDE EFFECT; SINGLE DRUG DOSE; SOCIAL SUPPORT; SOMNOLENCE; VOMITING; WORLD HEALTH ORGANIZATION;

ACUPUNCTURE THERAPY; AFFECT; COMPLEMENTARY THERAPIES; ENVIRONMENT; FOOD; HEALTH PROMOTION; HEALTH STATUS; HUMANS; LIFE STYLE; MASSAGE; VITAMINS;

EID: 36549066150     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2007.09.002     Document Type: Review

References (154)

1. Murray L., Hipwell A., Hooper R., et al. The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 37 8 (1996) 927-935
2. Birmaher B., Arbelaez C., and Brent D. Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am 11 3 (2002) 619-637 x
3. Zalsman G., Brent D.A., and Weersing V.R. Depressive disorders in childhood and adolescence: an overview: epidemiology, clinical manifestation and risk factors. Child Adolesc Psychiatr Clin N Am 15 4 (2006) 827-841 vii
4. Kowatch R.A., Fristad M., Birmaher B., et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44 3 (2005) 213-235
5. Pavuluri M.N., Birmaher B., and Naylor M.W. Pediatric bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 44 9 (2005) 846-871
6. Grzywacz J.G., Suerken C.K., Quandt S.A., et al. Older adults' use of complementary and alternative medicine for mental health: findings from the 2002 National Health Interview Survey. J Altern Complement Med 12 5 (2006) 467-473
7. Afifi M. Positive health practices and depressive symptoms among high school adolescents in Oman. Singapore Med J 47 11 (2006) 960-966
8. Hamre H.J., Witt C.M., Glockmann A., et al. Anthroposophic therapy for chronic depression: a four-year prospective cohort study. BMC Psychiatry 6 (2006) 57
9. Ludwig D.S. Clinical update: the low-glycaemic-index diet. Lancet 369 9565 (2007) 890-892
10. Kleinman R.E., Hall S., Green H., et al. Diet, breakfast, and academic performance in children. Ann Nutr Metab 46 Suppl 1 (2002) 24-30
11. Fulkerson J.A., Sherwood N.E., Perry C.L., et al. Depressive symptoms and adolescent eating and health behaviors: a multifaceted view in a population-based sample. Prev Med 38 6 (2004) 865-875
12. Allgower A., Wardle J., and Steptoe A. Depressive symptoms, social support, and personal health behaviors in young men and women. Health Psychol 20 3 (2001) 223-227
13. Bangash S.A., and Bahna S.L. Pediatric food allergy update. Curr Allergy Asthma Rep 5 6 (2005) 437-444
14. Bischoff S.C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 7 2 (2007) 93-104
15. Teufel M., Biedermann T., Rapps N., et al. Psychological burden of food allergy. World J Gastroenterol 13 25 (2007) 3456-3465
16. Christie L., Hine R.J., Parker J.G., et al. Food allergies in children affect nutrient intake and growth. J Am Diet Assoc 102 11 (2002) 1648-1651
17. Brown R.S. Exercise and mental health in the pediatric population. Clin Sports Med 1 3 (1982) 515-527
18. Anton S.D., Newton Jr. R.L., Sothern M., et al. Association of depression with body mass index, sedentary behavior, and maladaptive eating attitudes and behaviors in 11 to 13-year old children. Eat Weight Disord 11 3 (2006) e102-e108
19. Hulens M., Vansant G., Claessens A.L., et al. Health-related quality of life in physically active and sedentary obese women. Am J Hum Biol 14 6 (2002) 777-785
20. Pilkington K., Kirkwood G., Rampes H., et al. Yoga for depression: the research evidence. J Affect Disord 89 1-3 (2005) 13-24
21. Tsuno N., Besset A., and Ritchie K. Sleep and depression. J Clin Psychiatry 66 10 (2005) 1254-1269
22. Beauchemin K.M., and Hays P. Sunny hospital rooms expedite recovery from severe and refractory depressions. J Affect Disord 40 1-2 (1996) 49-51
23. Manuel J.S. Solar flair. Environ Health Perspect 111 2 (2003) A104-A107
24. Lam R.W., Levitt A.J., Levitan R.D., et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry 163 5 (2006) 805-812
25. Epperson C.N., Terman M., Terman J.S., et al. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry 65 3 (2004) 421-425
26. Golden R.N., Gaynes B.N., Ekstrom R.D., et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 162 4 (2005) 656-662
27. Martiny K. Adjunctive bright light in non-seasonal major depression. Acta Psychiatr Scand Suppl 425 (2004) 7-28
28. Frumkin H. Beyond toxicity: human health and the natural environment. Am J Prev Med 20 3 (2001) 234-240
29. Antonioli C., and Reveley M.A. Randomised controlled trial of animal facilitated therapy with dolphins in the treatment of depression. BMJ 331 7527 (2005) 1231
30. Ross W.D., and Sholiton M.C. Specificity of psychiatric manifestations in relation to neurotoxic chemicals. Acta Psychiatr Scand Suppl 303 (1983) 100-104
31. Schottenfeld R.S., and Cullen M.R. Organic affective illness associated with lead intoxication. Am J Psychiatry 141 11 (1984) 1423-1426
32. Johansson C., Castoldi A.F., Onishchenko N., et al. Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox Res 11 3-4 (2007) 241-260
33. Mikolajczyk R.T., Bredehorst M., Khelaifat N., et al. Correlates of depressive symptoms among Latino and non-Latino white adolescents: findings from the 2003 California Health Interview Survey. BMC Public Health 7 (2007) 21
34. Galea S., Ahern J., Nandi A., et al. Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol 17 3 (2007) 171-179
35. Siefert K., Finlayson T.L., Williams D.R., et al. Modifiable risk and protective factors for depressive symptoms in low-income African American mothers. Am J Orthopsychiatry 77 1 (2007) 113-123
36. Igartua K.J., Gill K., and Montoro R. Internalized homophobia: a factor in depression, anxiety, and suicide in the gay and lesbian population. Can J Commun Ment Health 22 2 (2003) 15-30
37. Borrell L.N., Kiefe C.I., Williams D.R., et al. Self-reported health, perceived racial discrimination, and skin color in African Americans in the CARDIA study. Soc Sci Med 63 6 (2006) 1415-1427
38. Whitbeck L.B., McMorris B.J., Hoyt D.R., et al. Perceived discrimination, traditional practices, and depressive symptoms among American Indians in the upper Midwest. J Health Soc Behav 43 4 (2002) 400-418
39. Szalacha L.A., Erkut S., Garcia Coll C., et al. Discrimination and Puerto Rican children's and adolescents' mental health. Cultur Divers Ethnic Minor Psychol 9 2 (2003) 141-155
40. Salzinger S., Rosario M., Feldman R.S., et al. Adolescent suicidal behavior: associations with preadolescent physical abuse and selected risk and protective factors. J Am Acad Child Adolesc Psychiatry 46 7 (2007) 859-866
41. Handwerker W.P. Childhood origins of depression: evidence from native and nonnative women in Alaska and the Russian Far East. J Womens Health 8 1 (1999) 87-94
42. Widom C.S., DuMont K., and Czaja S.J. A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up. Arch Gen Psychiatry 64 1 (2007) 49-56
43. Davidson R.J., Kabat-Zinn J., Schumacher J., et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 65 4 (2003) 564-570
44. Lazar S.W., Kerr C.E., Wasserman R.H., et al. Meditation experience is associated with increased cortical thickness. Neuroreport 16 17 (2005) 1893-1897
45. Rathus J.H., and Miller A.L. Dialectical behavior therapy adapted for suicidal adolescents. Suicide Life Threat Behav 32 2 (2002) 146-157
46. Katz L.Y., Cox B.J., Gunasekara S., et al. Feasibility of dialectical behavior therapy for suicidal adolescent inpatients. J Am Acad Child Adolesc Psychiatry 43 3 (2004) 276-282
47. Nelson-Gray R.O., Keane S.P., Hurst R.M., et al. A modified DBT skills training program for oppositional defiant adolescents: promising preliminary findings. Behav Res Ther 44 12 (2006) 1811-1820
48. Goldstein T.R., Axelson D.A., Birmaher B., et al. Dialectical behavior therapy for adolescents with bipolar disorder: a 1-year open trial. J Am Acad Child Adolesc Psychiatry 46 7 (2007) 820-830
49. van der Kolk B.A., Spinazzola J., Blaustein M.E., et al. A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry 68 1 (2007) 37-46
50. Wall R.B. Tai Chi and mindfulness-based stress reduction in a Boston public middle school. J Pediatr Health Care 19 4 (2005) 230-237
51. Gordon J.S., Staples J.K., Blyta A., et al. Treatment of posttraumatic stress disorder in postwar Kosovo high school students using mind-body skills groups: a pilot study. J Trauma Stress 17 2 (2004) 143-147
52. Hilliard R.E. The effects of music therapy-based bereavement groups on mood and behavior of grieving children: a pilot study. J Music Ther 38 4 (2001) 291-306
53. Cassileth B.R., Vickers A.J., and Magill L.A. Music therapy for mood disturbance during hospitalization for autologous stem cell transplantation: a randomized controlled trial. Cancer 98 12 (2003) 2723-2729
54. Weydert J.A., Shapiro D.E., Acra S.A., et al. Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial. BMC Pediatr 6 (2006) 29
55. Reynolds W.M., and Coats K.I. A comparison of cognitive-behavioral therapy and relaxation training for the treatment of depression in adolescents. J Consult Clin Psychol 54 5 (1986) 653-660
56. Murphy W.J., Talmadge C.L., Tubis A., et al. Relaxation dynamics of spontaneous otoacoustic emissions perturbed by external tones. I. Response to pulsed single-tone suppressors. J Acoust Soc Am 97 6 (1995) 3702-3710
57. Stein R.E., Zitner L.E., and Jensen P.S. Interventions for adolescent depression in primary care. Pediatrics 118 2 (2006) 669-682
58. Munoz K.A., Krebs-Smith S.M., Ballard-Barbash R., et al. Food intakes of US children and adolescents compared with recommendations. Pediatrics 100 3 Pt 1 (1997) 323-329
59. Gesch C.B., Hammond S.M., Hampson S.E., et al. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Br J Psychiatry 181 (2002) 22-28
60. Kaplan B.J., Simpson J.S., Ferre R.C., et al. Effective mood stabilization with a chelated mineral supplement: an open-label trial in bipolar disorder. J Clin Psychiatry 62 12 (2001) 936-944
61. Popper C.W. Do vitamins or minerals (apart from lithium) have mood-stabilizing effects?. J Clin Psychiatry 62 12 (2001) 933-935
62. Simmons M. Nutritional approach to bipolar disorder. J Clin Psychiatry 64 3 (2003) 338 [author reply 338-9]
63. Hvas A.M., Juul S., Bech P., et al. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom 73 6 (2004) 340-343
64. Wyatt K.M., Dimmock P.W., Jones P.W., et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 318 7195 (1999) 1375-1381
65. Dimopoulos N., Piperi C., Salonicioti A., et al. Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek population. Clin Biochem 40 9-10 (2007) 604-608
66. Tolmunen T., Voutilainen S., Hintikka J., et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 133 10 (2003) 3233-3236
67. Godfrey P.S., Toone B.K., Carney M.W., et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336 8712 (1990) 392-395
68. Papakostas G.I., Petersen T., Denninger J.W., et al. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol 24 5 (2004) 507-511
69. Bottiglieri T., Hyland K., Laundy M., et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med 22 4 (1992) 871-876
70. Coppen A., and Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 60 2 (2000) 121-130
71. Crellin R., Bottiglieri T., and Reynolds E.H. Folates and psychiatric disorders. Clinical potential. Drugs 45 5 (1993) 623-636
72. Cashman K.D. Vitamin D in childhood and adolescence. Postgrad Med J 83 978 (2007) 230-235
73. Olmez D., Bober E., Buyukgebiz A., et al. The frequency of vitamin D insufficiency in healthy female adolescents. Acta Paediatr 95 10 (2006) 1266-1269
74. Schnadower D., Agarwal C., Oberfield S.E., et al. Hypocalcemic seizures and secondary bilateral femoral fractures in an adolescent with primary vitamin D deficiency. Pediatrics 118 5 (2006) 2226-2230
75. Bergqvist A.G., Schall J.I., and Stallings V.A. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia 48 1 (2007) 66-71
76. Pappa H.M., Gordon C.M., Saslowsky T.M., et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118 5 (2006) 1950-1961
77. Sinnott B.P., and Licata A.A. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review. Endocr Pract 12 6 (2006) 622-629
78. Pepmueller P.H., Cassidy J.T., Allen S.H., et al. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 39 5 (1996) 746-757
79. Patel S., Farragher T., Berry J., et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56 7 (2007) 2143-2149
80. Khan S. Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease. Am J Med Sci 333 4 (2007) 201-207
81. Ford L., Graham V., Wall A., et al. Vitamin D concentrations in a UK inner-city multicultural outpatient population. Ann Clin Biochem 43 Pt 6 (2006) 468-473
82. Weng F.L., Shults J., Leonard M.B., et al. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr 86 1 (2007) 150-158
83. Calvo M.S., Whiting S.J., and Barton C.N. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 80 6 Suppl (2004) 1710S-1716S
84. Reinehr T., de Sousa G., Alexy U., et al. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 157 2 (2007) 225-232
85. Schneider B., Weber B., Frensch A., et al. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 107 7 (2000) 839-842
86. Armstrong D.J., Meenagh G.K., Bickle I., et al. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 26 4 (2007) 551-554
87. Lansdowne A.T., and Provost S.C. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl) 135 4 (1998) 319-323
88. Bohrer T., and Krannich J.H. Depression as a manifestation of latent chronic hypoparathyroidism. World J Biol Psychiatry 8 1 (2007) 56-59
89. Roman S., and Sosa J.A. Psychiatric and cognitive aspects of primary hyperparathyroidism. Curr Opin Oncol 19 1 (2007) 1-5
90. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr 19 2 (2000) 220-227
91. Bertone-Johnson E.R., Hankinson S.E., Bendich A., et al. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 165 11 (2005) 1246-1252
92. Dickerson L.M., Mazyck P.J., and Hunter M.H. Premenstrual syndrome. Am Fam Physician 67 8 (2003) 1743-1752
93. Thys-Jacobs S., Ceccarelli S., Bierman A., et al. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 4 3 (1989) 183-189
94. Heiden A., Frey R., Presslich O., et al. Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy. Psychiatry Res 89 3 (1999) 239-246
95. Siwek M., Wrobel A., Dudek D., et al. [The role of copper and magnesium in the pathogenesis and treatment of affective disorders]. Psychiatr Pol 39 5 (2005) 911-920 [in Polish]
96. Murck H. Magnesium and affective disorders. Nutr Neurosci 5 6 (2002) 375-389
97. Facchinetti F., Sances G., Borella P., et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31 5 (1991) 298-301
98. Giannini A.J., Nakoneczie A.M., Melemis S.M., et al. Magnesium oxide augmentation of verapamil maintenance therapy in mania. Psychiatry Res 93 1 (2000) 83-87
99. Schimatschek H.F., and Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 14 4 (2001) 283-290
100. Davidson J.R., Abraham K., Connor K.M., et al. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 53 3 (2003) 261-264
101. McLeod M.N., Gaynes B.N., and Golden R.N. Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients. J Clin Psychiatry 60 4 (1999) 237-240
102. Docherty J.P., Sack D.A., Roffman M., et al. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiatr Pract 11 5 (2005) 302-314
103. Nowak G., Szewczyk B., and Pilc A. Zinc and depression. An update. Pharmacol Rep 57 6 (2005) 713-718
104. Levenson C.W. Zinc: the new antidepressant?. Nutr Rev 64 1 (2006) 39-42
105. Lozoff B., Jimenez E., Hagen J., et al. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 105 4 (2000) E51
106. Rangan A.M., Blight G.D., and Binns C.W. Iron status and non-specific symptoms of female students. J Am Coll Nutr 17 4 (1998) 351-355
107. Conklin S.M., Harris J.I., Manuck S.B., et al. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res 152 1 (2007) 1-10
108. Garland M.R., Hallahan B., McNamara M., et al. Lipids and essential fatty acids in patients presenting with self-harm. Br J Psychiatry 190 (2007) 112-117
109. Hibbeln J.R. Fish consumption and major depression. Lancet 351 9110 (1998) 1213
110. Hibbeln J.R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 69 1-3 (2002) 15-29
111. Silvers K.M., and Scott K.M. Fish consumption and self-reported physical and mental health status. Public Health Nutr 5 3 (2002) 427-431
112. Hallahan B., Hibbeln J.R., Davis J.M., et al. Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry 190 (2007) 118-122
113. Nemets B., Stahl Z., and Belmaker R.H. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159 3 (2002) 477-479
114. Peet M., and Horrobin D.F. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59 10 (2002) 913-919
115. Su K.P., Shen W.W., and Huang S.Y. Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient. Eur Neuropsychopharmacol 11 4 (2001) 295-299
116. Stoll A.L., Locke C.A., Marangell L.B., et al. Omega-3 fatty acids and bipolar disorder: a review. Prostaglandins Leukot Essent Fatty Acids 60 5-6 (1999) 329-337
117. Stoll A.L., Severus W.E., Freeman M.P., et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56 5 (1999) 407-412
118. Keck Jr. P.E., and McElroy S.L. Carbamazepine and valproate in the maintenance treatment of bipolar disorder. J Clin Psychiatry 63 Suppl 10 (2002) 13-17
119. Wozniak J., Biederman J., Mick E., et al. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol 17 6-7 (2007) 440-447
120. Alino J.J., Gutierrez J.L., and Iglesias M.L. 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study. Int Pharmacopsychiatry 11 1 (1976) 8-15
121. Angst J., Woggon B., and Schoepf J. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. Arch Psychiatr Nervenkr 224 2 (1977) 175-186
122. Byerley W.F., Judd L.L., Reimherr F.W., et al. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects. J Clin Psychopharmacol 7 3 (1987) 127-137
123. Nolen W.A., van de Putte J.J., Dijken W.A., et al. L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine. Br J Psychiatry 147 (1985) 16-22
124. Turner E.H., Loftis J.M., and Blackwell A.D. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther 109 3 (2006) 325-338
125. van Hiele L.J. l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions. Neuropsychobiology 6 4 (1980) 230-240
126. Shaw K., Turner J., and Del Mar C. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev 1 (2002) CD003198
127. Das Y.T., Bagchi M., Bagchi D., et al. Safety of 5-hydroxy-L-tryptophan. Toxicol Lett 150 1 (2004) 111-122
128. AHRQ. S-Adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. In: AHRQ, editor. 2002. Available at: www.ahrq.gov/clinic/epcsums/melatsun.htm.
129. Pancheri P., Scapicchio P., and Chiaie R.D. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder. Int J Neuropsychopharmacol 5 4 (2002) 287-294
130. Hardy M.L., Coulter I., Morton S.C., et al. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. Evid Rep Technol Assess (Summ) 64 (2003) 1-3
131. Shippy R.A., Mendez D., Jones K., et al. S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS. BMC Psychiatry 4 (2004) 38
132. Williams A.L., Girard C., Jui D., et al. S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. Clin Invest Med 28 3 (2005) 132-139
133. Alpert J.E., Papakostas G., Mischoulon D., et al. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol 24 6 (2004) 661-664
134. Linde K., Mulrow C.D., Berner M., et al. St John's wort for depression. Cochrane Database Syst Rev 2 (2005) CD000448
135. Gastpar M., Singer A., and Zeller K. Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. Pharmacopsychiatry 38 2 (2005) 78-86
136. Gastpar M., Singer A., and Zeller K. Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry 39 2 (2006) 66-75
137. Findling R.L., McNamara N.K., O'Riordan M.A., et al. An open-label pilot study of St. John's wort in juvenile depression. J Am Acad Child Adolesc Psychiatry 42 8 (2003) 908-914
138. Simeon J., Nixon M.K., Milin R., et al. Open-label pilot study of St. John's wort in adolescent depression. J Child Adolesc Psychopharmacol 15 2 (2005) 293-301
139. Schulz V. Safety of St. John's wort extract compared to synthetic antidepressants. Phytomedicine 13 3 (2006) 199-204
140. Levine J. Controlled trials of inositol in psychiatry. Eur Neuropsychopharmacol 7 2 (1997) 147-155
141. Nierenberg A.A., Ostacher M.J., Calabrese J.R., et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 163 2 (2006) 210-216
142. Levine J., Witztum E., Greenberg B.D., et al. Inositol-induced mania?. Am J Psychiatry 153 6 (1996) 839
143. Jones N.A., and Field T. Massage and music therapies attenuate frontal EEG asymmetry in depressed adolescents. Adolescence 34 135 (1999) 529-534
144. Accortt E.E., and Allen J.J. Frontal EEG asymmetry and premenstrual dysphoric symptomatology. J Abnorm Psychol 115 1 (2006) 179-184
145. Field T., Hernandez-Reif M., Diego M., et al. Cortisol decreases and serotonin and dopamine increase following massage therapy. Int J Neurosci 115 10 (2005) 1397-1413
146. Field T., Diego M.A., Hernandez-Reif M., et al. Massage therapy effects on depressed pregnant women. J Psychosom Obstet Gynaecol 25 2 (2004) 115-122
147. Diego M.A., Field T., Hernandez-Reif M., et al. Aggressive adolescents benefit from massage therapy. Adolescence 37 147 (2002) 597-607
148. Field T., Morrow C., Valdeon C., et al. Massage reduces anxiety in child and adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry 31 1 (1992) 125-131
149. Weissman M.M., Wickramaratne P., Nomura Y., et al. Offspring of depressed parents: 20 years later. Am J Psychiatry 163 6 (2006) 1001-1008
150. Field T., Hernandez-Reif M., and Diego M. Newborns of depressed mothers who received moderate versus light pressure massage during pregnancy. Infant Behav Dev 29 1 (2006) 54-58
151. Leo R.J., and Ligot Jr. J.S. A systematic review of randomized controlled trials of acupuncture in the treatment of depression. J Affect Disord 97 1-3 (2007) 13-22
152. Manber R., Schnyer R.N., Allen J.J., et al. Acupuncture: a promising treatment for depression during pregnancy. J Affect Disord 83 1 (2004) 89-95
153. Mukaino Y., Park J., White A., et al. The effectiveness of acupuncture for depression-a systematic review of randomised controlled trials. Acupunct Med 23 2 (2005) 70-76
154. Kemper K.J., Sarah R., Silver-Highfield E., et al. On pins and needles? Pediatric pain patients' experience with acupuncture. Pediatrics 105 4 Pt 2 (2000) 941-947